4//SEC Filing
MCDONNELL MICHAEL R 4
Accession 0001127602-25-003964
CIK 0000875045other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:59 PM ET
Size
13.3 KB
Accession
0001127602-25-003964
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
MCDONNELL MICHAEL R
EVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-02-07$141.35/sh−786$111,101→ 20,955 total - Exercise/Conversion
Common Stock
2025-02-07+2,335→ 21,741 total - Tax Payment
Common Stock
2025-02-07$141.35/sh−716$101,207→ 22,455 total - Exercise/Conversion
Restricted Stock Unit
2025-02-07−2,216→ 4,434 totalExercise: $0.00Exp: 2027-02-07→ Common Stock (2,216 underlying) - Exercise/Conversion
Common Stock
2025-02-07+2,216→ 23,171 total - Exercise/Conversion
Restricted Stock Unit
2025-02-07−2,335→ 2,335 totalExercise: $0.00Exp: 2026-02-08→ Common Stock (2,335 underlying)
Footnotes (2)
- [F1]The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023.
- [F2]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001121897
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 6:59 PM ET
- Size
- 13.3 KB